10 Best Sliver Stocks To Invest In Right Now

Chinese Internet companies aren't racing back into fashion, but naysayers are starting to clear out of the world's most populous nation.

The market exchanges are out with their latest tallies on short sales, and the number of bearish wagers as of mid-April have been falling sharply for many of the country's bellwethers.

There were just 2.2 million shares of Dangdang (NYSE: DANG  ) sold short. That's a 52-week low for the Chinese e-tailer, and well below the 9.6 million shares that were sold short in May of last year. SINA (NASDAQ: SINA  ) also clocked in with a new low. There were just 1.8 million shares in bearish wagers against the online portal behind the Twitter-like SINA Weibo platform. There were 9 million shares sold short 10 months ago. Renren (NYSE: RENN  ) came in at 3.8 million shares sold short, near its low of 3.1 million just two weeks earlier. There were 24.9 million shares of Renren borrowed by skeptics of the leading social networking website operator in May of last year.

The exodus isn't universal. Youku Tudou (NYSE: YOKU  ) �had 11.2 million shorted shares as of mid-April. The leading video streaming website hasn't had this many naysayers since late last year.

10 Best Sliver Stocks To Invest In Right Now: S&W Seed Company(SANW)

S&W Seed Company engages in contracting the production of alfalfa seed varieties, processing the seeds, and marketing the certified seed to agribusiness firms and farmers worldwide. It also involves in the production of stevia leaf. The company primarily offers high fall dormancy (FD) alfalfa seed varieties, as well as markets and sells other varieties, including FD 7, 6, and 4 varieties. It sells the seed primarily to dealers and distributors who, in turn, sell primarily to hay and dairy farmers who grow hay for dairy cattle and other livestock; and through brokers. The company was founded in 1980 and is headquartered in Five Points, California.

Advisors' Opinion:

• [By Glenwoods]

  �PureCircle does not grow its own product, but is more of a holding company as it contracts farms scattered around the globe to grow stevia to certain specifications.� One such farm is the S&W SEED Co. (NASDAQ:SANW).� Toward the end of 2011, PureCircle, with a goal of developing stevia in the U.S. for the U.S market, entered into a five-year agreementwith the California-based grower of high-yield alfalfa seeds, to grow stevia to the company�� specifications.� Unfortunately the results have not matched expectationsas reported by S&W Seed:

10 Best Sliver Stocks To Invest In Right Now: Sino-Global Shipping America Ltd.(SINO)

Sino-Global Shipping America, Ltd., through its subsidiaries, provides shipping agency services for foreign ships coming to and departing from Chinese ports. Its services include preparing documents, husbanding vessels, working through customs issues, coordinating matters with port authorities, overseeing and settling cargo claims, tracking shipments, recommending trucking, warehousing, and complementary services. The company offers these services for bulk and break-bulk general cargo, and vehicle transport, as well as raw materials, such as crude oil, oil products, iron, manganese, and other metal ores in 76 ports in the People?s Republic of China. Sino-Global Shipping America, Ltd. was founded in 2001 and is based in Flushing, Virginia.

Advisors' Opinion:

• [By James E. Brumley]

  The recent strength from Sino-Global Shipping America, Ltd. (NASDAQ:SINO) and the now-renewed strength from Safe Bulkers, Inc. (NYSE:SB) would suggest those two stocks are among the very best ways to play the rebound currently unfurling in the shipping sector. And to be fair, both are fine companies in their own right. The top play in the dry goods maritime shipping arena, however, may well be Diana Shipping Inc. (NYSE:DSX). No, DSX isn't one of the fun and exciting small caps in the maritime shipping space. But, there's a lot to be said for size and stability, which SB and SINO can't offer.

Best New Stocks To Watch Right Now: Rutter Inc (RUT)

Rutter Inc. (Rutter) focuses on providing technologies and manufacturing solutions. The Company supplies technologies to improve efficiency and safety in the marine, defense, transportation, oil and gas sectors. The Company produces and globally markets enhanced radar systems, including oil spill detection, ice navigator, small target detection and wave-monitoring systems. The Company also offers a full range of outsource manufacturing services including: product engineering and design; materials management; manufacturing; sub-assembly; systems integration; project management; testing; logistics and documentation and provides full cycle customer support for all Company products and selected third party components/products that it manufactures under contract. Rutter�� sigma S6 radar signal processing products are designed to enable end users to detect and track objects which would not be visible with conventional radar equipment only. Advisors' Opinion:

• [By Carla Mozée]

  U.S. stocks closed Monday�� session higher, led by small-cap and tech companies. Analysts noted that Wall Street�� trading volumes were the third-lowest this year, saying an absence of ��ad news��helped support gains. Among key benchmarks, the Nasdaq Composite (COMP) �rose 0.9%, and the Russell 2000 (RUT) index of small stocks ended 1% higher.

• [By Anora Mahmudova]

  The Russell 2000 index of small-cap stocks (RUT) � fell 32.30 points, or 2.8%, to 1,127.66. Panic-selling was evident from the jump in the volatility. The CBOE Vix index (VIX) � of implied volatility on the S&P 500 jumped 15% to nearly 16.

• [By Victor Reklaitis]

  Meanwhile, the Russell 2000 index (RUT) , a gauge of small-cap stocks, was up 20.88 points, or 1.9%, at 1,099.97. Some eyebrows were raised Wednesday when the Russell diverged, ending lower as the S&P 500 gained ground. The Russell, however, outpaced the S&P 500 on Friday, though it still slightly underperformed for the week, gaining 0.4%.

10 Best Sliver Stocks To Invest In Right Now: Provectus Pharmaceuticals Inc (PVCT)

Provectus Pharmaceuticals, Inc., incorporated on May 1, 1978, is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications. The Company develops and focuses to license or market and sells its two prescription drug candidates, PV-10 and PH-10. The Company has transferred all its intellectual property related to over the counter (OTC) products and non-core technologies to its subsidiaries and designated, such subsidiaries as non-core to its primary business of developing its oncology and dermatology prescription drug candidates. The Company focuses on developing its prescription drug candidates PV-10 and PH-10. The Company is developing PV-10 for treatment of several life threatening cancers, including metastatic melanoma, liver cancer, and breast cancer. The Company is developing PH-10 to provide minimally invasive treatment of chronic severe skin afflictions such as psoriasis and atopic dermatitis, a type of eczema. All of the Company's prescription drug candidates are in either the pre-clinical or clinical trial stage.

PV-10

As of December 31, 2011, the Company is developing PV-10, a sterile injectible form of rose bengal disodium (Rose Bengal), for direct injection into tumors. Its PV-10 is retained in diseased or damaged tissue but dissipates from healthy tissue. The Company had conducted Phase I and Phase IIstudies of PV-10 for the treatment of metastatic melanoma, and Phase I studies of PV-10 for the treatment of liver and breast cancers.

PH-10

The Company�� prescription drug candidate PH-10 is an aqueous hydrogel formulation of Rose Bengal for topical administration to the skin. The Company is developing PH-10 for the treatment of cutaneous skin disorders, specifically psoriasis and atopic dermatitis. In August 2011, the Company completed follow-up of all Phase IIc patients.

Over-the-Counter Pharmaceuticals

The Company had desi! gnated its subsidiary that holds its OTC products, GloveAid and Pure-ific, Pure-Stick, Pure N Clear as non-core. The Company�� GloveAid is a hand cream with both antiperspirant and antibacterial properties, for the comfort of users��hands during and after the wearing of disposable gloves. Its Pure-ific line of products includes two quick-drying sprays, Pure-ific and Pure-ific Kids, that immediately kill up to 99.9% of germs on skin and prevent regrowth for six hours. Pure-ific products prevent the spread of germs and thus complement its other OTC products designed to treat irritated skin or skin conditions, such as acne, eczema, dandruff and fungal infections. Its Pure-ific sprays have been designed with convenience in mind and are targeted towards mothers, travelers, and anyone concerned about the spread of sickness-causing germs.

The Company�� acne products Pure-Stick and Pure N Clear work by decreasing the production of fats, oils and sweat that create an environment conducive to unchecked growth of bacteria. Secondly, the products also act to reduce the number bacteria already present. The Pure-Stick and Pure N Clear are applied topically to affected areas there are no safety concerns with healthy skin.

Advisors' Opinion:

• [By Luke Jacobi]

  Provectus Biopharmaceuticals (NYSE: PVCT) was also down, falling 3.38 percent to $3.01, letting out some air after the company's opening on the NYSE Friday.

10 Best Sliver Stocks To Invest In Right Now: Morgan Stanley Technology Etf (MTK)

SPDR Morgan Stanley Technology (ETF) (the Fund), formerly Morgan Stanley Technology ETF, seeks to replicate as closely as possible the performance of the Morgan Stanley Technology Index (the Index). The Fund utilizes a passive or indexing approach and attempts to approximate the investment performance of its benchmark Index, by investing in a portfolio of stocks intended to replicate the index.

The Fund�� industry breakdown includes communications equipment, software, computers and peripherals, semiconductors and semiconductor equipment, information technology (IT) services, Internet software and services, Internet and catalog retail, and electronic equipment and instruments. The Fund�� portfolio includes AMAZON.COM, INC, FIRST DATA CORP., JUNIPER NETWORKS, INC., APPLE, INC. and EMC CORP.

Advisors' Opinion:

• [By Selena Maranjian]

  Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some tech-heavy stocks to your portfolio, but don't have the time or expertise to hand-pick a few, the SPDR Morgan Stanley Technology ETF (NYSEMKT: MTK  ) could save you a lot of trouble. Instead of trying to figure out which companies will perform best, you can use this technology ETF to invest in lots of them simultaneously.
  
  The basics
  ETFs often sport lower expense ratios than their mutual fund cousins. The technology ETF's expense ratio -- its annual fee -- is a relatively low 0.50%. The fund is fairly small, too, so if you're thinking of buying, beware of possibly large spreads between its bid and ask prices. Consider using a limit order if you want to buy in.

10 Best Sliver Stocks To Invest In Right Now: Woolworths Ltd (WOW)

Woolworths Limited is an Australia-based company. The Company operates in five segments: Australian Food and Liquor, New Zealand Supermarkets, Petrol, BIG W and Hotels. Australian Food and Liquor segment is engaged in the procurement of food and liquor and products for resale to customers in Australia. New Zealand Supermarkets segment is engaged in the procurement of food and liquor and products for resale to customers in New Zealand. Petrol segment is engaged in the procurement of petroleum products for resale to customers in Australia. BIG W segment is engaged procurement of discount general merchandise products for resale to customers in Australia. Hotels segment is engaged in the provision of leisure and hospitality services, including food and alcohol, accommodation, entertainment and gaming. Advisors' Opinion:

• [By Jonathan Burgos]

  Woolworths Ltd. (WOW) dropped 1.6 percent to A$33.22 after Australia�� largest retailer said challenging economic condition were evident in the second quarter.

10 Best Sliver Stocks To Invest In Right Now: Peregrine Pharmaceuticals Inc.(PPHM)

Peregrine Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the research and development of monoclonal antibodies for the treatment of cancer and viral infections. Its products under development include bavituximab, a phosphatidylserine-targeting antibody, which is in Phase II trials for the treatment of front-line and second-line non-small cell lung cancer (NSCLC), and pancreatic cancer; and Cotara, a DNA/histone-targeting antibody that is in Phase II trial for the treatment of recurrent glioblastoma multiforme. The company is also developing bavituximab in combination with ribavirin, which is in Phase II clinical trial for the treatment of patients with genotype-1 hepatitis C virus infection. In addition, it has investigator-sponsored trial programs that evaluate bavituximab for the treatment of patients with liver cancer, second-line castration resistant prostate cancer, HER-2 negative metastatic breast cancer, and locally advanced or metasta tic NSCLC. Further, the company, through its wholly-owned subsidiary, Avid Bioservices, Inc., provides integrated current Good Manufacturing Practices (cGMP) commercial and clinical manufacturing services in the United States, including contract manufacturing of antibodies, recombinant proteins, and enzymes; cell culture development; process development; and testing of biologics for biopharmaceutical and biotechnology companies under cGMP. It has licensing agreements with the University of Texas Southwestern Medical Center; Merck KGaA; SuperGen, Inc.; and Affitech A/S. Peregrine Pharmaceuticals, Inc. intends to sell its products in the United States and internationally in collaboration with marketing partners or through a direct sales force. The company was founded in 1981 and is based in Tustin, California.

Advisors' Opinion:

• [By Rick Munarriz]

  Peregrine Pharmaceuticals (NASDAQ: PPHM  ) is an upstart biotech targeting the treatment and diagnosis of cancer through monoclonal antibodies. It has a potential winner in its lead candidate that will begin its telltale phase 3 clinical trial later this year.

• [By Sean Williams]

  What: Shares of Peregrine Pharmaceuticals (NASDAQ: PPHM  ) , a biopharmaceutical company developing monoclonal antibodies to treat cancer, jumped as much as 19% after the company reported final data on its mid-stage second-line non-small cell lung cancer drug, Bavituximab, at the annual American Society of Clinical Oncology meeting.

• [By Rick Munarriz]

  I went out on a limb last week, and now it's time to see how that decision played out.

  I predicted that Noodles & Co. (NASDAQ: NDLS  ) would close lower on the week. After seeing the fresh IPO more than double and command a $1.3 billion market cap far sooner than its fundamentals should allow, I figured it would be in for reality check. A negative Barron's piece kicked off the week in the seemingly appropriate bearish tone, but the shares did start to claw their way back later in the week. It wasn't enough. The shares fell 3% on the week. I was right. I predicted that the tech-heavy Nasdaq would outperform the Dow Jones Industrial Average. (DJINDICES: ^DJI  ) . This has been a tricky call lately, so how did it play out this time? Well, the market closed nicely higher this week. The Nasdaq moved 3.5% higher, and the Dow managed to close just 2.2% higher. I was right. My final call was for Peregrine Pharmaceuticals (NASDAQ: PPHM  ) to beat Wall Street's income estimates in its latest quarter. The upstart biotech tackling cancer through monoclonal antibodies has been posting blowout quarterly results over the past year, and I was banking on seeing the trend continue. Analysts were looking for a loss of $0.06 a share during the quarter, and it came through with exactly that. It wasn't a beat, though, so I was wrong.

  Two out of three? I can do better than that.

• [By Sean Williams]

  Also gaining double digits on the week was the highly embattled Peregrine Pharmaceuticals (NASDAQ: PPHM  ) which rallied after the FDA approved its late-stage trial design for its second-line non-small-cell lung cancer immunotherapy, Bavituximab. While trial design approvals are rarely big news, it is in this case because mid-stage results for Bavituximab have been all over the place. At first Bavituximab demonstrated a better than doubling in progression-free survival followed weeks later by management's insistence that investors were not to trust the data. A few months later, following a review, we were told to trust the data again. This filing helps relieve some of the confusion surrounding Peregrine's mid-stage results, and hopefully its phase 3 study will be black-and-white obvious as to whether Bavituximab provides a statistically significant benefit.

10 Best Sliver Stocks To Invest In Right Now: Achillion Pharmaceuticals Inc.(ACHN)

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for infectious diseases. The company focuses on the development of antivirals for the treatment of chronic hepatitis C; and the development of antibacterials for the treatment of resistant bacterial infections. Its drug candidates for the treatment of chronic HCV include ACH-1625, a protease inhibitor, which is in phase IIa clinical trial for the treatment of chronic HCV; ACH-2684, a pangenotypic protease inhibitor, which is in phase I clinical trial for the treatment of chronic HCV infection; and NS5A inhibitors for the treatment of chronic HCV infection, including ACH-2928, which is to enter a phase I clinical trial, as well as various additional NS5A inhibitors in preclinical development. Its pipeline of product candidates also includes ACH-702 and ACH-2881 for drug resistant bacterial infections; elvucitabine for HIV infection; and AC H-1095 for HCV infection. The company was founded in 1998 and is based in New Haven, Connecticut.

Advisors' Opinion:

• [By Lauren Pollock]

  Among the companies with shares expected to actively trade in Monday’s session are Achillion Pharmaceuticals Inc.(ACHN), Active Network Inc.(ACTV) and Harvest Natural Resources Inc.(HNR)

• [By Dan Carroll]

  Few biotechs were hit as hard as Achillion Pharmaceuticals (NASDAQ: ACHN  ) this week, however. Achillion makes up around 2% of the weight of the SPDR Biotech ETF, and its 7.5% loss this week was a major reason for the fund's fall. This stock has failed to capitalize on the markets' surge this year, losing 10% year-to-date. The company only recently named a new CEO, lifting its former R&D head and chief science officer to the top job. Achillion's still in the developmental stage of its life and thus produces no revenue, and the company's cash burn makes it seem likely that more share dilution is on its way as the company looks to advance its hepatitis-C pipeline over the coming years. Until Achillion produces some meaningful results from that pipeline, this stock will remain a risky play in an already risky space.

10 Best Sliver Stocks To Invest In Right Now: Anhanguera Educacional Participacoes SA (AEDU3)

Anhanguera Educacional Participacoes SA, formerly Mehir Holdings SA, is a Brazil-based holding company engaged in the education sector. The Company provides higher graduate and postgraduate education through full time and distance learning programs. It is also engaged in the provision of preparatory courses for public competition and other specialization courses. The Company offers the academic programs, such as full time graduate, distance graduate and post-graduate courses. Additionally, the Company provides selected courses through the methodology of distance learning, including graduate, post-graduate and continuous education courses. Anhanguera Educacional Participacoes SA offers its services for working adults and operates in approximately 71 campuses and around 500 learning centers located throughout each of around the 26 Brazilian states. Advisors' Opinion:

• [By Ney Hayashi]

  Anhanguera Educacional Participacoes SA (AEDU3) tumbled after Brazil�� antitrust regulator signaled it may limit the education company�� merger with competitor Kroton Educacional SA. (KROT3) Lojas Renner SA (LREN3) led retailers higher after a report showed Brazil�� industrial production expanded faster than expected in October, easing concern that growth is faltering.

10 Best Sliver Stocks To Invest In Right Now: Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund (ETO)

Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund (the Fund) is a closed-end management investment company. The Fund's investment objective is to provide a high level of after-tax total return. The Fund pursues its objective by investing primarily in dividend-paying common and preferred stocks.

The Fund�� top 10 equity holdings include Freeport-McMoran Copper, Veolia Environment, Southern Copper Corp., Societe Generale, Chevron Corp., Occidental Petroleum Corp., Exelon Corp., Total SA Spon ADR, Entergy Corp. and Suncor Energy Inc. Top 10 equity holdings represented 25.3% of total investments as of April 30, 2007.

Advisors' Opinion:

• [By GURUFOCUS]

  Special Purpose Funds- Eaton Vance Tax-Adv. Global Dividend Oppor. Fund (ETO) | Yield: 7.3%
  - The Gabelli Global Utility & Income Trust (GLU) | Yield: 6.2%
  - Pimco Global Stocksplus Income Fund (PGP) | Yield: 9.5%
  - LMP Real Estate Income Fund Inc. (RIT) | Yield: 7.0%